Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Rivaroxaban 1mg/ml granules for oral suspension sugar free |
| BNF code | 0208020Y0AAAFAF |
| Virtual Therapeutic Moiety | Rivaroxaban |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Date of name applicability | 1 Apr 2024 |
| Previous name | Rivaroxaban 1mg/ml oral suspension sugar free |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✓ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Continuous |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Rivaroxaban |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 1.000 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | suspension.oral |
| Dose Form | |
| Formulation | Granules for oral suspension |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Xarelto 1mg/ml granules for oral suspension (Bayer Plc) | |
| Virtual Medicinal Product Packs | |
| Rivaroxaban 1mg/ml granules for oral suspension sugar free 100 ml | |
| Rivaroxaban 1mg/ml granules for oral suspension sugar free 250 ml | |
| Rivaroxaban 1mg/ml granules for oral suspension sugar free 50 ml | |
dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.